|
WO2002076925A2
(en)
*
|
2001-03-23 |
2002-10-03 |
Eli Lilly And Company |
Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
|
|
US6825198B2
(en)
*
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
JP4467307B2
(ja)
|
2002-02-22 |
2010-05-26 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
５−ｈｔ受容体アンタゴニストとしてのピリジルスルホン誘導体
|
|
US7314937B2
(en)
|
2002-03-21 |
2008-01-01 |
Eli Lilly And Company |
Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
|
|
SE0201544D0
(sv)
*
|
2002-05-17 |
2002-05-17 |
Biovitrum Ab |
Novel compounds and thier use
|
|
US6989392B2
(en)
|
2002-06-18 |
2006-01-24 |
Abbott Laboratories |
2-Aminoquinolines as melanin concentrating hormone receptor antagonists
|
|
US7226925B2
(en)
|
2002-06-19 |
2007-06-05 |
Biovitrum Ab |
Compounds, their use and preparation
|
|
AU2003243089B2
(en)
*
|
2002-06-19 |
2010-01-07 |
Biovitrum Ab (Publ) |
Novel compounds, their use and preparation
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
GB0215775D0
(en)
*
|
2002-07-06 |
2002-08-14 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
CN102558155A
(zh)
|
2003-01-14 |
2012-07-11 |
阿伦纳药品公司 |
作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
DK1603893T3
(da)
*
|
2003-01-29 |
2008-09-08 |
Asterand Uk Ltd |
EP4 -Receptorantagonister
|
|
CL2004000826A1
(es)
*
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
TWI335328B
(en)
|
2003-07-14 |
2011-01-01 |
Arena Pharm Inc |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
|
|
JP4765627B2
(ja)
|
2003-09-22 |
2011-09-07 |
Ｍｓｄ株式会社 |
新規ピペリジン誘導体
|
|
MXPA06003615A
(es)
*
|
2003-09-30 |
2006-06-05 |
Amgen Inc |
Ligandos del receptor vanilloide y su uso en tratamientos.
|
|
JP4529116B2
(ja)
*
|
2003-10-16 |
2010-08-25 |
東レ・ファインケミカル株式会社 |
高純度トリチルピペラジン誘導体の製造方法
|
|
WO2005053688A1
(en)
|
2003-11-26 |
2005-06-16 |
Alcon, Inc. |
Substituted furo[2,3-g] indazoles for the treatment of glaucoma
|
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
|
EP1694670A1
(en)
*
|
2003-12-16 |
2006-08-30 |
GPC Biotech AG |
Pyrazine derivatives as effective compounds against infectious diseases
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
EP1792629A4
(en)
|
2004-08-25 |
2010-08-25 |
Takeda Pharmaceutical |
MEANS FOR THE PREVENTION / TREATMENT OF STRESS-RELATED HARNINE INCONTINENCE AND PRECAUTIONARY METHOD FOR THIS
|
|
ES2325773T5
(es)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals, Llc. |
Tratamiento de la obesidad y de los trastornos relacionados
|
|
MX2007012082A
(es)
|
2005-03-31 |
2007-11-20 |
Pfizer Prod Inc |
Derivados de ciclopentapiridina y tetrahidroquinolina.
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
US8138206B2
(en)
|
2005-05-30 |
2012-03-20 |
Msd. K.K. |
Piperidine derivative
|
|
CA2618112A1
(en)
|
2005-08-10 |
2007-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Pyridone compound
|
|
AU2006279680B2
(en)
|
2005-08-11 |
2012-12-06 |
Amylin Pharmaceuticals, Llc |
Hybrid polypeptides with selectable properties
|
|
BRPI0614649A2
(pt)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
polipeptìdeos hìbridos com propriedades selecionáveis
|
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
|
AU2006288153A1
(en)
|
2005-09-07 |
2007-03-15 |
Msd K.K. |
Bicyclic aromatic substituted pyridone derivative
|
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
|
CA2627139A1
(en)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
Novel benzoxathiin derivative
|
|
ES2381205T3
(es)
|
2005-11-10 |
2012-05-24 |
Msd K.K. |
Derivado espiro aza-sustituido
|
|
EP2727585A1
(en)
|
2006-05-16 |
2014-05-07 |
Takeda Pharmaceutical Company Limited |
In-vivo screening method
|
|
US8173629B2
(en)
|
2006-09-22 |
2012-05-08 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
WO2008047544A1
(en)
|
2006-09-28 |
2008-04-24 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
DK2118279T3
(en)
|
2007-01-16 |
2018-02-26 |
Ipintl Llc |
HIS UNKNOWN COMPOSITION FOR TREATMENT OF METABOLIC SYNDROME
|
|
JP5319518B2
(ja)
|
2007-04-02 |
2013-10-16 |
Ｍｓｄ株式会社 |
インドールジオン誘導体
|
|
MX2009013293A
(es)
|
2007-06-04 |
2010-02-15 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2216023A4
(en)
|
2007-11-15 |
2013-03-13 |
Takeda Pharmaceutical |
CONDENSED PYRIDINE DERIVATIVE AND ITS USE
|
|
JPWO2009110510A1
(ja)
|
2008-03-06 |
2011-07-14 |
Ｍｓｄ株式会社 |
アルキルアミノピリジン誘導体
|
|
US20110015198A1
(en)
|
2008-03-28 |
2011-01-20 |
Banyu Pharmaceutical Co., Inc. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
CA2666036C
(en)
|
2008-05-16 |
2017-09-12 |
Chien-Hung Chen |
Novel compositions and methods for treating hyperproliferative diseases
|
|
JPWO2009154132A1
(ja)
|
2008-06-19 |
2011-12-01 |
Ｍｓｄ株式会社 |
スピロジアミン−ジアリールケトオキシム誘導体
|
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
JPWO2010013595A1
(ja)
|
2008-07-30 |
2012-01-12 |
Ｍｓｄ株式会社 |
５員−５員又は５員−６員縮環シクロアルキルアミン誘導体
|
|
EP2348857B1
(en)
|
2008-10-22 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
EP2350010B1
(en)
|
2008-10-30 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
AU2011218830B2
(en)
|
2010-02-25 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US20130267500A1
(en)
|
2010-09-01 |
2013-10-10 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
MX2013003184A
(es)
|
2010-09-22 |
2013-06-07 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de transtornos relacionados con el mismo.
|
|
MX348131B
(es)
|
2011-02-25 |
2017-05-26 |
Merck Sharp & Dohme |
Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos.
|
|
CA3100941C
(en)
|
2011-03-01 |
2024-03-05 |
Synergy Pharmaceuticals Inc. |
Process of preparing guanylate cyclase c agonists
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
WO2013102145A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
DK3738434T3
(da)
|
2011-12-28 |
2023-12-04 |
Global Blood Therapeutics Inc |
Mellemprodukter til opnåelse af substituerede benzaldehydforbindelser og fremgangsmåder til anvendelse deraf ved øgning af vævsoxygenering
|
|
MX2014014308A
(es)
*
|
2012-05-30 |
2015-02-12 |
Hoffmann La Roche |
Pirrolidino heterociclos.
|
|
WO2014022528A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
BR112015021982B1
(pt)
|
2013-03-15 |
2022-12-13 |
Global Blood Therapeutics, Inc |
Compostos e seus usos para a modulação de hemoglobina
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
AU2014237330A1
(en)
|
2013-03-15 |
2015-09-17 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
|
KR102280614B1
(ko)
|
2013-03-15 |
2021-07-21 |
글로벌 블러드 테라퓨틱스, 인크. |
헤모글로빈 조정을 위한 화합물 및 이의 용도
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EA201592263A1
(ru)
|
2013-06-05 |
2016-05-31 |
Синерджи Фармасьютикалз, Инк. |
Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
SI3102208T2
(sl)
|
2014-02-07 |
2024-10-30 |
Global Blood Therapeutics, Inc. |
Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
|
|
EP3186242B1
(en)
|
2014-08-29 |
2021-10-06 |
Tes Pharma S.r.l. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
AU2016205361C1
(en)
|
2015-01-06 |
2021-04-08 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
PL3310760T3
(pl)
|
2015-06-22 |
2023-03-06 |
Arena Pharmaceuticals, Inc. |
Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
|
|
US11020382B2
(en)
|
2015-12-04 |
2021-06-01 |
Global Blood Therapeutics, Inc. |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
KR20190116416A
(ko)
|
2017-02-16 |
2019-10-14 |
아레나 파마슈티칼스, 인크. |
원발 담즙성 담관염을 치료하기 위한 화합물 및 방법
|
|
JPWO2019131902A1
(ja)
|
2017-12-27 |
2020-12-10 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
|
AU2019280822A1
(en)
|
2018-06-06 |
2021-01-07 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the S1P1 receptor
|
|
EP3860975B1
(en)
|
2018-10-01 |
2023-10-18 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
EP3923933A4
(en)
|
2019-02-13 |
2022-08-17 |
Merck Sharp & Dohme Corp. |
PYRROLIDINOREXINE RECEPTOR AGONISTS
|
|
TW202045476A
(zh)
|
2019-02-13 |
2020-12-16 |
美商默沙東藥廠 |
5-烷基吡咯啶食慾素受體促效劑
|
|
WO2020252229A2
(en)
*
|
2019-06-14 |
2020-12-17 |
Disarm Therapeutics, Inc. |
Inhibitors of sarm1
|
|
WO2021026047A1
(en)
|
2019-08-08 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
MX2023001840A
(es)
|
2020-08-18 |
2023-03-13 |
Merck Sharp & Dohme Llc |
Agonistas de bicicloheptano pirrolidina de los receptores de orexina.
|
|
PH12023553248A1
(en)
*
|
2021-06-02 |
2024-03-25 |
Univ North Carolina Chapel Hill |
Rna-targeting ligands, compositions thereof, and methods of making and using the same
|